nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Retinoid metabolism and transport—RBP1—stomach cancer	0.0393	0.107	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—RBP4—stomach cancer	0.0201	0.0546	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—RBP1—stomach cancer	0.0201	0.0544	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1C3—stomach cancer	0.0168	0.0456	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—RBP4—stomach cancer	0.0103	0.0279	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—stomach cancer	0.00941	0.0255	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOA1—stomach cancer	0.00907	0.0246	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1C3—stomach cancer	0.0086	0.0233	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—MTHFR—stomach cancer	0.00828	0.0224	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOA1—stomach cancer	0.00762	0.0206	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—stomach cancer	0.00615	0.0166	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SERPINE1—stomach cancer	0.00605	0.0164	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—stomach cancer	0.00604	0.0164	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL1B—stomach cancer	0.00491	0.0133	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.0048	0.013	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOA1—stomach cancer	0.00463	0.0126	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.00402	0.0109	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—stomach cancer	0.00357	0.00966	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ACAD8—stomach cancer	0.00331	0.00898	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.00324	0.00878	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.00305	0.00825	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GMPR2—stomach cancer	0.00295	0.008	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—stomach cancer	0.00288	0.0078	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.00285	0.00773	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.00282	0.00764	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SUCLG1—stomach cancer	0.0027	0.00732	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—IDH3B—stomach cancer	0.0027	0.00732	CbGpPWpGaD
Gentamicin—LRP2—Disease—PGLS—stomach cancer	0.00267	0.00724	CbGpPWpGaD
Gentamicin—LRP2—Disease—RBP1—stomach cancer	0.00255	0.00691	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NDUFV1—stomach cancer	0.00251	0.00681	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NDUFS1—stomach cancer	0.00251	0.00681	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.00246	0.00665	CbGpPWpGaD
Gentamicin—Deafness—Docetaxel—stomach cancer	0.00239	0.00379	CcSEcCtD
Gentamicin—Stomatitis—Irinotecan—stomach cancer	0.00232	0.00368	CcSEcCtD
Gentamicin—Dizziness—Mitomycin—stomach cancer	0.00232	0.00367	CcSEcCtD
Gentamicin—Vascular purpura—Capecitabine—stomach cancer	0.00231	0.00367	CcSEcCtD
Gentamicin—Deafness—Capecitabine—stomach cancer	0.00231	0.00367	CcSEcCtD
Gentamicin—Oliguria—Methotrexate—stomach cancer	0.0023	0.00365	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—stomach cancer	0.00228	0.00361	CcSEcCtD
Gentamicin—LRP2—Disease—FBP1—stomach cancer	0.00227	0.00616	CbGpPWpGaD
Gentamicin—Visual disturbance—Docetaxel—stomach cancer	0.00226	0.00358	CcSEcCtD
Gentamicin—Injection site pain—Doxorubicin—stomach cancer	0.00225	0.00357	CcSEcCtD
Gentamicin—LRP2—Metabolism—BLVRB—stomach cancer	0.00224	0.00607	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PGLS—stomach cancer	0.00224	0.00607	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Fluorouracil—stomach cancer	0.00224	0.00355	CcSEcCtD
Gentamicin—Vomiting—Mitomycin—stomach cancer	0.00223	0.00353	CcSEcCtD
Gentamicin—Stomatitis—Fluorouracil—stomach cancer	0.00223	0.00353	CcSEcCtD
Gentamicin—Rash—Mitomycin—stomach cancer	0.00221	0.0035	CcSEcCtD
Gentamicin—Dermatitis—Mitomycin—stomach cancer	0.00221	0.0035	CcSEcCtD
Gentamicin—Headache—Mitomycin—stomach cancer	0.00219	0.00348	CcSEcCtD
Gentamicin—Lethargy—Docetaxel—stomach cancer	0.00218	0.00346	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—stomach cancer	0.00217	0.00344	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—stomach cancer	0.00216	0.00342	CcSEcCtD
Gentamicin—Purpura—Capecitabine—stomach cancer	0.00215	0.00341	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPAP2A—stomach cancer	0.00214	0.00579	CbGpPWpGaD
Gentamicin—Agranulocytosis—Fluorouracil—stomach cancer	0.00213	0.00338	CcSEcCtD
Gentamicin—Lethargy—Capecitabine—stomach cancer	0.00211	0.00335	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—stomach cancer	0.00211	0.00334	CcSEcCtD
Gentamicin—Nausea—Mitomycin—stomach cancer	0.00208	0.0033	CcSEcCtD
Gentamicin—Visual impairment—Irinotecan—stomach cancer	0.00206	0.00327	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.00205	0.00556	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Fluorouracil—stomach cancer	0.00204	0.00323	CcSEcCtD
Gentamicin—LRP2—Disease—PGAM1—stomach cancer	0.00203	0.00549	CbGpPWpGaD
Gentamicin—Hypocalcaemia—Doxorubicin—stomach cancer	0.00201	0.00318	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—stomach cancer	0.002	0.00316	CcSEcCtD
Gentamicin—LRP2—Disease—WIF1—stomach cancer	0.00193	0.00524	CbGpPWpGaD
Gentamicin—Salivary hypersecretion—Epirubicin—stomach cancer	0.00193	0.00306	CcSEcCtD
Gentamicin—LRP2—Metabolism—CA1—stomach cancer	0.0019	0.00516	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CKB—stomach cancer	0.0019	0.00516	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NDUFA2—stomach cancer	0.0019	0.00516	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—FBP1—stomach cancer	0.0019	0.00516	CbGpPWpGaD
Gentamicin—Alopecia—Irinotecan—stomach cancer	0.00189	0.003	CcSEcCtD
Gentamicin—Hypokalaemia—Capecitabine—stomach cancer	0.00188	0.00299	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KISS1R—stomach cancer	0.00187	0.00507	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GLI3—stomach cancer	0.00187	0.00507	CbGpPWpGaD
Gentamicin—Muscular weakness—Capecitabine—stomach cancer	0.00183	0.00289	CcSEcCtD
Gentamicin—LRP2—Disease—RPL13—stomach cancer	0.00182	0.00492	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPL18—stomach cancer	0.00182	0.00492	CbGpPWpGaD
Gentamicin—Alopecia—Fluorouracil—stomach cancer	0.00181	0.00287	CcSEcCtD
Gentamicin—LRP2—Metabolism—PLIN2—stomach cancer	0.00179	0.00485	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RBP1—stomach cancer	0.00179	0.00484	CbGpPWpGaD
Gentamicin—Salivary hypersecretion—Doxorubicin—stomach cancer	0.00179	0.00283	CcSEcCtD
Gentamicin—Erythema—Fluorouracil—stomach cancer	0.00178	0.00283	CcSEcCtD
Gentamicin—LRP2—Metabolism—CA2—stomach cancer	0.00174	0.00472	CbGpPWpGaD
Gentamicin—LRP2—Disease—RNF43—stomach cancer	0.00172	0.00467	CbGpPWpGaD
Gentamicin—Anaemia—Irinotecan—stomach cancer	0.00172	0.00273	CcSEcCtD
Gentamicin—LRP2—Metabolism—PGAM1—stomach cancer	0.0017	0.0046	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NT5E—stomach cancer	0.0017	0.0046	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS21—stomach cancer	0.00169	0.00459	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS15—stomach cancer	0.00169	0.00459	CbGpPWpGaD
Gentamicin—Phlebitis—Epirubicin—stomach cancer	0.00167	0.00265	CcSEcCtD
Gentamicin—Vertigo—Irinotecan—stomach cancer	0.00167	0.00265	CcSEcCtD
Gentamicin—Weight decreased—Docetaxel—stomach cancer	0.00167	0.00265	CcSEcCtD
Gentamicin—Leukopenia—Irinotecan—stomach cancer	0.00167	0.00264	CcSEcCtD
Gentamicin—Anaemia—Fluorouracil—stomach cancer	0.00165	0.00261	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—stomach cancer	0.00163	0.00258	CcSEcCtD
Gentamicin—Weight decreased—Capecitabine—stomach cancer	0.00162	0.00257	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALDH7A1—stomach cancer	0.00162	0.00439	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLCE1—stomach cancer	0.00162	0.00439	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Docetaxel—stomach cancer	0.00162	0.00256	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—stomach cancer	0.00161	0.00256	CcSEcCtD
Gentamicin—Hypertension—Irinotecan—stomach cancer	0.00161	0.00255	CcSEcCtD
Gentamicin—Stomatitis—Docetaxel—stomach cancer	0.00161	0.00255	CcSEcCtD
Gentamicin—Leukopenia—Fluorouracil—stomach cancer	0.0016	0.00253	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—stomach cancer	0.00159	0.00252	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—stomach cancer	0.00157	0.00249	CcSEcCtD
Gentamicin—Neuropathy peripheral—Capecitabine—stomach cancer	0.00156	0.00248	CcSEcCtD
Gentamicin—Stomatitis—Capecitabine—stomach cancer	0.00156	0.00247	CcSEcCtD
Gentamicin—LRP2—Metabolism—UMPS—stomach cancer	0.00155	0.0042	CbGpPWpGaD
Gentamicin—Phlebitis—Doxorubicin—stomach cancer	0.00155	0.00246	CcSEcCtD
Gentamicin—Convulsion—Fluorouracil—stomach cancer	0.00155	0.00245	CcSEcCtD
Gentamicin—Agranulocytosis—Docetaxel—stomach cancer	0.00154	0.00244	CcSEcCtD
Gentamicin—Confusional state—Irinotecan—stomach cancer	0.00153	0.00243	CcSEcCtD
Gentamicin—Anaphylactic shock—Irinotecan—stomach cancer	0.00152	0.00241	CcSEcCtD
Gentamicin—Purpura—Epirubicin—stomach cancer	0.0015	0.00237	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—stomach cancer	0.00149	0.00237	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—stomach cancer	0.00149	0.00236	CcSEcCtD
Gentamicin—Agranulocytosis—Capecitabine—stomach cancer	0.00149	0.00236	CcSEcCtD
Gentamicin—Thrombocytopenia—Irinotecan—stomach cancer	0.00149	0.00236	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00149	0.00403	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Docetaxel—stomach cancer	0.00147	0.00233	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—stomach cancer	0.00147	0.00233	CcSEcCtD
Gentamicin—Confusional state—Fluorouracil—stomach cancer	0.00147	0.00233	CcSEcCtD
Gentamicin—Anaphylactic shock—Fluorouracil—stomach cancer	0.00146	0.00231	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—WWOX—stomach cancer	0.00146	0.00394	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PDHA1—stomach cancer	0.00144	0.00391	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ECHS1—stomach cancer	0.00144	0.00391	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Fluorouracil—stomach cancer	0.00143	0.00226	CcSEcCtD
Gentamicin—Visual impairment—Docetaxel—stomach cancer	0.00143	0.00226	CcSEcCtD
Gentamicin—Hypoaesthesia—Capecitabine—stomach cancer	0.00143	0.00226	CcSEcCtD
Gentamicin—Hypotension—Irinotecan—stomach cancer	0.00142	0.00225	CcSEcCtD
Gentamicin—LRP2—Disease—ALDOB—stomach cancer	0.0014	0.00381	CbGpPWpGaD
Gentamicin—Purpura—Doxorubicin—stomach cancer	0.00138	0.0022	CcSEcCtD
Gentamicin—Visual impairment—Capecitabine—stomach cancer	0.00138	0.00219	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.00138	0.00219	CcSEcCtD
Gentamicin—LRP2—Disease—RPL15—stomach cancer	0.00138	0.00373	CbGpPWpGaD
Gentamicin—Paraesthesia—Irinotecan—stomach cancer	0.00137	0.00216	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—stomach cancer	0.00136	0.00216	CcSEcCtD
Gentamicin—Hypotension—Fluorouracil—stomach cancer	0.00136	0.00216	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMP—stomach cancer	0.00136	0.00368	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—FADS1—stomach cancer	0.00136	0.00368	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—WIF1—stomach cancer	0.00135	0.00367	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRH4—stomach cancer	0.00135	0.00367	CbGpPWpGaD
Gentamicin—LRP2—Disease—NPM1—stomach cancer	0.00135	0.00366	CbGpPWpGaD
Gentamicin—Tinnitus—Capecitabine—stomach cancer	0.00134	0.00212	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00133	0.0021	CcSEcCtD
Gentamicin—Decreased appetite—Irinotecan—stomach cancer	0.00132	0.0021	CcSEcCtD
Gentamicin—Eosinophilia—Methotrexate—stomach cancer	0.00132	0.00209	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—stomach cancer	0.00131	0.00208	CcSEcCtD
Gentamicin—Paraesthesia—Fluorouracil—stomach cancer	0.00131	0.00207	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—stomach cancer	0.00131	0.00207	CcSEcCtD
Gentamicin—LRP2—Disease—RBP4—stomach cancer	0.00131	0.00354	CbGpPWpGaD
Gentamicin—Erythema—Docetaxel—stomach cancer	0.00129	0.00204	CcSEcCtD
Gentamicin—LRP2—Disease—RPS26—stomach cancer	0.00128	0.00348	CbGpPWpGaD
Gentamicin—LRP2—Disease—PPIA—stomach cancer	0.00127	0.00345	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.00127	0.00345	CbGpPWpGaD
Gentamicin—Muscular weakness—Epirubicin—stomach cancer	0.00127	0.00202	CcSEcCtD
Gentamicin—LRP2—Metabolism—SREBF2—stomach cancer	0.00127	0.00344	CbGpPWpGaD
Gentamicin—Decreased appetite—Fluorouracil—stomach cancer	0.00127	0.00201	CcSEcCtD
Gentamicin—Alopecia—Capecitabine—stomach cancer	0.00127	0.00201	CcSEcCtD
Gentamicin—LRP2—Metabolism—RORA—stomach cancer	0.00126	0.0034	CbGpPWpGaD
Gentamicin—Feeling abnormal—Irinotecan—stomach cancer	0.00125	0.00199	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKAB1—stomach cancer	0.00125	0.00338	CbGpPWpGaD
Gentamicin—Erythema—Capecitabine—stomach cancer	0.00125	0.00198	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—stomach cancer	0.00123	0.00196	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—stomach cancer	0.00121	0.00193	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KISS1—stomach cancer	0.00121	0.00327	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RNF43—stomach cancer	0.00121	0.00327	CbGpPWpGaD
Gentamicin—Body temperature increased—Irinotecan—stomach cancer	0.0012	0.00191	CcSEcCtD
Gentamicin—Feeling abnormal—Fluorouracil—stomach cancer	0.0012	0.0019	CcSEcCtD
Gentamicin—Anaemia—Docetaxel—stomach cancer	0.00119	0.00189	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—stomach cancer	0.00118	0.00187	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALDOB—stomach cancer	0.00118	0.00319	CbGpPWpGaD
Gentamicin—Stomatitis—Methotrexate—stomach cancer	0.00116	0.00184	CcSEcCtD
Gentamicin—Urticaria—Fluorouracil—stomach cancer	0.00116	0.00183	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—stomach cancer	0.00115	0.00183	CcSEcCtD
Gentamicin—Anaemia—Capecitabine—stomach cancer	0.00115	0.00183	CcSEcCtD
Gentamicin—Body temperature increased—Fluorouracil—stomach cancer	0.00115	0.00182	CcSEcCtD
Gentamicin—Eosinophilia—Doxorubicin—stomach cancer	0.00114	0.00181	CcSEcCtD
Gentamicin—Weight decreased—Epirubicin—stomach cancer	0.00113	0.00179	CcSEcCtD
Gentamicin—Vertigo—Capecitabine—stomach cancer	0.00112	0.00178	CcSEcCtD
Gentamicin—Hypersensitivity—Irinotecan—stomach cancer	0.00112	0.00178	CcSEcCtD
Gentamicin—Leukopenia—Capecitabine—stomach cancer	0.00112	0.00177	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—stomach cancer	0.00112	0.00177	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—stomach cancer	0.00111	0.00176	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.00111	0.003	CbGpPWpGaD
Gentamicin—Agranulocytosis—Methotrexate—stomach cancer	0.00111	0.00176	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.00111	0.003	CbGpPWpGaD
Gentamicin—Arthralgia—Docetaxel—stomach cancer	0.0011	0.00174	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALOX5—stomach cancer	0.00109	0.00296	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKR1C3—stomach cancer	0.00109	0.00296	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS19—stomach cancer	0.00109	0.00296	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—stomach cancer	0.00109	0.00173	CcSEcCtD
Gentamicin—Stomatitis—Epirubicin—stomach cancer	0.00108	0.00172	CcSEcCtD
Gentamicin—Hypertension—Capecitabine—stomach cancer	0.00108	0.00171	CcSEcCtD
Gentamicin—LRP2—Metabolism—DPYD—stomach cancer	0.00108	0.00291	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FST—stomach cancer	0.00108	0.00291	CbGpPWpGaD
Gentamicin—Hypersensitivity—Fluorouracil—stomach cancer	0.00107	0.0017	CcSEcCtD
Gentamicin—LRP2—Disease—ENO1—stomach cancer	0.00106	0.00288	CbGpPWpGaD
Gentamicin—Arthralgia—Capecitabine—stomach cancer	0.00106	0.00168	CcSEcCtD
Gentamicin—Confusional state—Docetaxel—stomach cancer	0.00106	0.00168	CcSEcCtD
Gentamicin—Anaphylactic shock—Docetaxel—stomach cancer	0.00105	0.00167	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—stomach cancer	0.00104	0.00165	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—stomach cancer	0.00104	0.00164	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GAST—stomach cancer	0.00104	0.00281	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RGS2—stomach cancer	0.00104	0.00281	CbGpPWpGaD
Gentamicin—Pruritus—Fluorouracil—stomach cancer	0.00103	0.00163	CcSEcCtD
Gentamicin—Thrombocytopenia—Docetaxel—stomach cancer	0.00103	0.00163	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—stomach cancer	0.00103	0.00163	CcSEcCtD
Gentamicin—Confusional state—Capecitabine—stomach cancer	0.00103	0.00163	CcSEcCtD
Gentamicin—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00101	0.0016	CcSEcCtD
Gentamicin—Dizziness—Irinotecan—stomach cancer	0.00101	0.00159	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—stomach cancer	0.001	0.00159	CcSEcCtD
Gentamicin—Thrombocytopenia—Capecitabine—stomach cancer	0.000997	0.00158	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—stomach cancer	0.000994	0.00158	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—stomach cancer	0.000993	0.00157	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGG—stomach cancer	0.000983	0.00266	CbGpPWpGaD
Gentamicin—Hypotension—Docetaxel—stomach cancer	0.000982	0.00156	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000975	0.00264	CbGpPWpGaD
Gentamicin—Vomiting—Irinotecan—stomach cancer	0.000967	0.00153	CcSEcCtD
Gentamicin—LRP2—Disease—RPS6—stomach cancer	0.000966	0.00262	CbGpPWpGaD
Gentamicin—Dizziness—Fluorouracil—stomach cancer	0.000963	0.00153	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—stomach cancer	0.000962	0.00152	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—stomach cancer	0.00096	0.00152	CcSEcCtD
Gentamicin—Rash—Irinotecan—stomach cancer	0.000959	0.00152	CcSEcCtD
Gentamicin—Dermatitis—Irinotecan—stomach cancer	0.000958	0.00152	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000958	0.00152	CcSEcCtD
Gentamicin—Headache—Irinotecan—stomach cancer	0.000953	0.00151	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTT1—stomach cancer	0.000951	0.00258	CbGpPWpGaD
Gentamicin—Hypotension—Capecitabine—stomach cancer	0.000951	0.00151	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKAA1—stomach cancer	0.000947	0.00256	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD44—stomach cancer	0.000944	0.00256	CbGpPWpGaD
Gentamicin—Paraesthesia—Docetaxel—stomach cancer	0.000944	0.0015	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—stomach cancer	0.000942	0.00149	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2A6—stomach cancer	0.00094	0.00255	CbGpPWpGaD
Gentamicin—Tinnitus—Epirubicin—stomach cancer	0.000931	0.00147	CcSEcCtD
Gentamicin—Erythema—Methotrexate—stomach cancer	0.000928	0.00147	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000927	0.00147	CcSEcCtD
Gentamicin—Vomiting—Fluorouracil—stomach cancer	0.000926	0.00147	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—stomach cancer	0.000919	0.00146	CcSEcCtD
Gentamicin—Rash—Fluorouracil—stomach cancer	0.000918	0.00146	CcSEcCtD
Gentamicin—Dermatitis—Fluorouracil—stomach cancer	0.000917	0.00145	CcSEcCtD
Gentamicin—LRP2—Metabolism—AKR1C3—stomach cancer	0.000915	0.00248	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RBP4—stomach cancer	0.000914	0.00248	CbGpPWpGaD
Gentamicin—Paraesthesia—Capecitabine—stomach cancer	0.000914	0.00145	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—stomach cancer	0.000914	0.00145	CcSEcCtD
Gentamicin—Headache—Fluorouracil—stomach cancer	0.000912	0.00145	CcSEcCtD
Gentamicin—Nausea—Irinotecan—stomach cancer	0.000903	0.00143	CcSEcCtD
Gentamicin—LRP2—Metabolism—ENO1—stomach cancer	0.000891	0.00242	CbGpPWpGaD
Gentamicin—Visual impairment—Doxorubicin—stomach cancer	0.00089	0.00141	CcSEcCtD
Gentamicin—LRP2—Disease—HBEGF—stomach cancer	0.000888	0.0024	CbGpPWpGaD
Gentamicin—Decreased appetite—Capecitabine—stomach cancer	0.000885	0.0014	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—stomach cancer	0.000882	0.0014	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000877	0.00238	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—stomach cancer	0.000869	0.00138	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—stomach cancer	0.000866	0.00137	CcSEcCtD
Gentamicin—Nausea—Fluorouracil—stomach cancer	0.000865	0.00137	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—stomach cancer	0.000861	0.00136	CcSEcCtD
Gentamicin—Anaemia—Methotrexate—stomach cancer	0.000858	0.00136	CcSEcCtD
Gentamicin—Feeling abnormal—Capecitabine—stomach cancer	0.000839	0.00133	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—stomach cancer	0.000834	0.00132	CcSEcCtD
Gentamicin—Body temperature increased—Docetaxel—stomach cancer	0.000831	0.00132	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—stomach cancer	0.000831	0.00132	CcSEcCtD
Gentamicin—Alopecia—Doxorubicin—stomach cancer	0.000816	0.00129	CcSEcCtD
Gentamicin—Urticaria—Capecitabine—stomach cancer	0.000809	0.00128	CcSEcCtD
Gentamicin—Body temperature increased—Capecitabine—stomach cancer	0.000805	0.00128	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—stomach cancer	0.000804	0.00127	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—stomach cancer	0.000804	0.00127	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—stomach cancer	0.000803	0.00127	CcSEcCtD
Gentamicin—LRP2—Disease—PPP2R1A—stomach cancer	0.000803	0.00217	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CD44—stomach cancer	0.000791	0.00214	CbGpPWpGaD
Gentamicin—Arthralgia—Methotrexate—stomach cancer	0.00079	0.00125	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HSPB1—stomach cancer	0.000786	0.00213	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGTR2—stomach cancer	0.000786	0.00213	CbGpPWpGaD
Gentamicin—Vertigo—Epirubicin—stomach cancer	0.000781	0.00124	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—stomach cancer	0.000778	0.00123	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—BMP2—stomach cancer	0.000777	0.00211	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—F2R—stomach cancer	0.000777	0.00211	CbGpPWpGaD
Gentamicin—Hypersensitivity—Docetaxel—stomach cancer	0.000775	0.00123	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000767	0.00208	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKR1C3—stomach cancer	0.000765	0.00207	CbGpPWpGaD
Gentamicin—Confusional state—Methotrexate—stomach cancer	0.000764	0.00121	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—stomach cancer	0.000758	0.0012	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HTR1A—stomach cancer	0.000757	0.00205	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—stomach cancer	0.000753	0.00119	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—stomach cancer	0.00075	0.00119	CcSEcCtD
Gentamicin—Hypersensitivity—Capecitabine—stomach cancer	0.00075	0.00119	CcSEcCtD
Gentamicin—LRP2—Disease—SMAD4—stomach cancer	0.000745	0.00202	CbGpPWpGaD
Gentamicin—Pruritus—Docetaxel—stomach cancer	0.000744	0.00118	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—stomach cancer	0.000743	0.00118	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—stomach cancer	0.000742	0.00118	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—stomach cancer	0.00074	0.00117	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ANXA1—stomach cancer	0.000731	0.00198	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—stomach cancer	0.000722	0.00114	CcSEcCtD
Gentamicin—Pruritus—Capecitabine—stomach cancer	0.00072	0.00114	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—stomach cancer	0.00072	0.00114	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—stomach cancer	0.000715	0.00113	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—stomach cancer	0.000709	0.00112	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—stomach cancer	0.000708	0.00112	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ADRB1—stomach cancer	0.000708	0.00192	CbGpPWpGaD
Gentamicin—LRP2—Disease—FYN—stomach cancer	0.000708	0.00192	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—stomach cancer	0.000697	0.0011	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—stomach cancer	0.000695	0.0011	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—stomach cancer	0.000694	0.0011	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—stomach cancer	0.000694	0.0011	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00069	0.00109	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—stomach cancer	0.000684	0.00108	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—stomach cancer	0.00068	0.00108	CcSEcCtD
Gentamicin—LRP2—Disease—ERCC2—stomach cancer	0.00068	0.00184	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RPS6—stomach cancer	0.000676	0.00183	CbGpPWpGaD
Gentamicin—Dizziness—Capecitabine—stomach cancer	0.000673	0.00107	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPP2R1A—stomach cancer	0.000672	0.00182	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—stomach cancer	0.000668	0.00106	CcSEcCtD
Gentamicin—LRP2—Disease—FGFR2—stomach cancer	0.000664	0.0018	CbGpPWpGaD
Gentamicin—Rash—Docetaxel—stomach cancer	0.000663	0.00105	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—stomach cancer	0.000663	0.00105	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—stomach cancer	0.000662	0.00105	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—stomach cancer	0.000662	0.00105	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTP1—stomach cancer	0.000659	0.00179	CbGpPWpGaD
Gentamicin—Decreased appetite—Methotrexate—stomach cancer	0.000659	0.00104	CcSEcCtD
Gentamicin—Headache—Docetaxel—stomach cancer	0.000659	0.00104	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000656	0.00104	CcSEcCtD
Gentamicin—LRP2—Metabolism—HMOX1—stomach cancer	0.00065	0.00176	CbGpPWpGaD
Gentamicin—Vomiting—Capecitabine—stomach cancer	0.000647	0.00103	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000647	0.00175	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000646	0.00102	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000642	0.00102	CcSEcCtD
Gentamicin—Rash—Capecitabine—stomach cancer	0.000642	0.00102	CcSEcCtD
Gentamicin—Dermatitis—Capecitabine—stomach cancer	0.000641	0.00102	CcSEcCtD
Gentamicin—LRP2—Disease—MTHFR—stomach cancer	0.000639	0.00173	CbGpPWpGaD
Gentamicin—Headache—Capecitabine—stomach cancer	0.000638	0.00101	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—stomach cancer	0.000637	0.00101	CcSEcCtD
Gentamicin—Nausea—Docetaxel—stomach cancer	0.000624	0.00099	CcSEcCtD
Gentamicin—Feeling abnormal—Methotrexate—stomach cancer	0.000624	0.00099	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HBEGF—stomach cancer	0.000622	0.00168	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—stomach cancer	0.000616	0.000977	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—stomach cancer	0.000613	0.000972	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMS—stomach cancer	0.000613	0.00166	CbGpPWpGaD
Gentamicin—LRP2—Disease—IRS2—stomach cancer	0.000608	0.00165	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—stomach cancer	0.000606	0.00164	CbGpPWpGaD
Gentamicin—Nausea—Capecitabine—stomach cancer	0.000605	0.000958	CcSEcCtD
Gentamicin—Urticaria—Methotrexate—stomach cancer	0.000602	0.000954	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—stomach cancer	0.000599	0.000949	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000598	0.000947	CcSEcCtD
Gentamicin—LRP2—Disease—CAV1—stomach cancer	0.00059	0.0016	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—stomach cancer	0.000589	0.000934	CcSEcCtD
Gentamicin—LRP2—Disease—APOA1—stomach cancer	0.000588	0.00159	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—stomach cancer	0.000584	0.000926	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ADRB2—stomach cancer	0.000574	0.00155	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—stomach cancer	0.00057	0.000904	CcSEcCtD
Gentamicin—LRP2—Metabolism—ERCC2—stomach cancer	0.00057	0.00154	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—stomach cancer	0.000563	0.000893	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPP2R1A—stomach cancer	0.000562	0.00152	CbGpPWpGaD
Gentamicin—Body temperature increased—Epirubicin—stomach cancer	0.000561	0.000888	CcSEcCtD
Gentamicin—LRP2—Disease—IL6ST—stomach cancer	0.000559	0.00151	CbGpPWpGaD
Gentamicin—Hypersensitivity—Methotrexate—stomach cancer	0.000558	0.000885	CcSEcCtD
Gentamicin—Feeling abnormal—Doxorubicin—stomach cancer	0.000541	0.000857	CcSEcCtD
Gentamicin—LRP2—Disease—APC—stomach cancer	0.000537	0.00146	CbGpPWpGaD
Gentamicin—Pruritus—Methotrexate—stomach cancer	0.000536	0.00085	CcSEcCtD
Gentamicin—LRP2—Metabolism—MTHFR—stomach cancer	0.000535	0.00145	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—stomach cancer	0.000522	0.000828	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SMAD4—stomach cancer	0.000522	0.00141	CbGpPWpGaD
Gentamicin—Urticaria—Doxorubicin—stomach cancer	0.000521	0.000826	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—stomach cancer	0.000519	0.000822	CcSEcCtD
Gentamicin—Pruritus—Epirubicin—stomach cancer	0.000502	0.000795	CcSEcCtD
Gentamicin—Dizziness—Methotrexate—stomach cancer	0.000501	0.000794	CcSEcCtD
Gentamicin—LRP2—Disease—IL6R—stomach cancer	0.000499	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FYN—stomach cancer	0.000496	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAV1—stomach cancer	0.000494	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOA1—stomach cancer	0.000493	0.00134	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—stomach cancer	0.000483	0.000766	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—stomach cancer	0.000482	0.000764	CcSEcCtD
Gentamicin—Rash—Methotrexate—stomach cancer	0.000478	0.000757	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—stomach cancer	0.000477	0.000757	CcSEcCtD
Gentamicin—Headache—Methotrexate—stomach cancer	0.000475	0.000752	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	0.000472	0.00128	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—stomach cancer	0.000469	0.000743	CcSEcCtD
Gentamicin—LRP2—Disease—SERPINE1—stomach cancer	0.000467	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR2—stomach cancer	0.000465	0.00126	CbGpPWpGaD
Gentamicin—Pruritus—Doxorubicin—stomach cancer	0.000464	0.000736	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—stomach cancer	0.000451	0.000715	CcSEcCtD
Gentamicin—LRP2—Disease—RHOA—stomach cancer	0.000451	0.00122	CbGpPWpGaD
Gentamicin—Nausea—Methotrexate—stomach cancer	0.00045	0.000713	CcSEcCtD
Gentamicin—Rash—Epirubicin—stomach cancer	0.000447	0.000709	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—stomach cancer	0.000447	0.000708	CcSEcCtD
Gentamicin—LRP2—Disease—NOS3—stomach cancer	0.000446	0.00121	CbGpPWpGaD
Gentamicin—Headache—Epirubicin—stomach cancer	0.000444	0.000704	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPARG—stomach cancer	0.000434	0.00118	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—stomach cancer	0.000434	0.000688	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IRS2—stomach cancer	0.000426	0.00115	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—stomach cancer	0.000421	0.000668	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—stomach cancer	0.000417	0.000661	CcSEcCtD
Gentamicin—LRP2—Disease—ERBB2—stomach cancer	0.000417	0.00113	CbGpPWpGaD
Gentamicin—Rash—Doxorubicin—stomach cancer	0.000414	0.000656	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—stomach cancer	0.000413	0.000655	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CAV1—stomach cancer	0.000413	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOA1—stomach cancer	0.000412	0.00112	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—stomach cancer	0.000411	0.000651	CcSEcCtD
Gentamicin—LRP2—Disease—PTGS2—stomach cancer	0.000408	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCB—stomach cancer	0.000393	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6ST—stomach cancer	0.000392	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—stomach cancer	0.00039	0.00106	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—stomach cancer	0.00039	0.000618	CcSEcCtD
Gentamicin—LRP2—Disease—CDKN1B—stomach cancer	0.000386	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—stomach cancer	0.000376	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NOS3—stomach cancer	0.000373	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—stomach cancer	0.000357	0.000966	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6R—stomach cancer	0.000349	0.000946	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000344	0.000933	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—stomach cancer	0.000342	0.000925	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—stomach cancer	0.000327	0.000886	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—stomach cancer	0.000318	0.000862	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RHOA—stomach cancer	0.000316	0.000855	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOS3—stomach cancer	0.000312	0.000846	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK3—stomach cancer	0.000304	0.000823	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—stomach cancer	0.000296	0.000801	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—stomach cancer	0.000292	0.000791	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000292	0.00079	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK1—stomach cancer	0.000289	0.000784	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—stomach cancer	0.000289	0.000783	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—stomach cancer	0.000277	0.000751	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—stomach cancer	0.000273	0.00074	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—stomach cancer	0.000271	0.000733	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—stomach cancer	0.000258	0.000699	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUN—stomach cancer	0.000258	0.000698	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—stomach cancer	0.000251	0.00068	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—stomach cancer	0.000251	0.000679	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—stomach cancer	0.00025	0.000676	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK8—stomach cancer	0.000244	0.00066	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—stomach cancer	0.000232	0.000629	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—stomach cancer	0.000225	0.00061	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—stomach cancer	0.000223	0.000604	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—stomach cancer	0.000222	0.000602	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000221	0.000599	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—stomach cancer	0.000213	0.000577	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—stomach cancer	0.00021	0.000569	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—stomach cancer	0.000207	0.000561	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK1—stomach cancer	0.000203	0.000549	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—stomach cancer	0.000202	0.000549	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—stomach cancer	0.000191	0.000518	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—stomach cancer	0.000176	0.000476	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	0.000175	0.000474	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—stomach cancer	0.00017	0.000461	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—stomach cancer	0.000163	0.00044	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—stomach cancer	0.000156	0.000422	CbGpPWpGaD
